News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
215,283 Results
Type
Article (35292)
Company Profile (11)
Press Release (179979)
Multimedia
Podcasts (13)
Webinars (10)
Section
Business (64249)
Career Advice (586)
Deals (5233)
Drug Delivery (17)
Drug Development (28003)
Employer Resources (46)
FDA (4111)
Job Trends (3953)
News (95880)
Policy (5656)
Tag
Academia (2653)
Academic (1)
Accelerated approval (17)
ADA (15)
Adcomms (10)
Allergies (70)
Alliances (13081)
ALS (72)
Alzheimer's disease (709)
Antibody-drug conjugate (ADC) (127)
Approvals (4321)
Artificial intelligence (208)
ASCO (124)
Autoimmune disease (94)
Automation (15)
Bankruptcy (23)
Best Places to Work (3243)
BIO (8)
BIOSECURE Act (4)
Biosimilars (29)
Biotechnology (11)
Bladder cancer (48)
Brain cancer (35)
Breast cancer (272)
Cancer (2023)
Cardiovascular disease (188)
Career advice (536)
Career pathing (12)
CAR-T (124)
CDC (25)
Cell therapy (312)
Cervical cancer (15)
Clinical research (23936)
Collaboration (520)
Company closure (1)
Compensation (41)
Complete response letters (8)
COVID-19 (1289)
CRISPR (46)
C-suite (873)
Cystic fibrosis (51)
Data (3349)
Decentralized trials (2)
Denatured (7)
Depression (66)
Dermatology (26)
Diabetes (198)
Diagnostics (2282)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (22)
Drug discovery (89)
Drug pricing (20)
Drug shortages (5)
Duchenne muscular dystrophy (60)
Earnings (9507)
Editorial (12)
Employer branding (2)
Employer resources (45)
Events (25975)
Executive appointments (768)
FDA (5016)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (11)
Funding (614)
Gene editing (88)
Generative AI (10)
Gene therapy (222)
GLP-1 (238)
Government (1152)
Grass and pollen (1)
Guidances (54)
Healthcare (6242)
Hematology (74)
HIV (29)
Huntington's disease (14)
IgA nephropathy (41)
Immunology and inflammation (48)
Immuno-oncology (28)
Indications (47)
Infectious disease (1398)
Inflammatory bowel disease (72)
Inflation Reduction Act (1)
Influenza (44)
Intellectual property (63)
Interviews (80)
IPO (2400)
IRA (8)
Job creations (779)
Job search strategy (471)
JPM (5)
Kidney cancer (9)
Labor market (21)
Layoffs (58)
Leadership (6)
Legal (925)
Liver cancer (29)
Longevity (8)
Lung cancer (222)
Lymphoma (178)
Machine learning (22)
Management (11)
Manufacturing (162)
MASH (83)
Medical device (3799)
Medtech (3843)
Mergers & acquisitions (2995)
Metabolic disorders (407)
mRNA (68)
Multiple sclerosis (57)
NASH (8)
Neurodegenerative disease (155)
Neuropsychiatric disorders (28)
Neuroscience (1231)
Neurotech (1)
NextGen: Class of 2026 (2133)
Non-profit (2005)
Now hiring (10)
Obesity (124)
Opinion (53)
Ovarian cancer (91)
Pain (77)
Pancreatic cancer (115)
Parkinson's disease (131)
Partnered (8)
Patents (106)
Patient recruitment (261)
Peanut (29)
People (36657)
Pharmaceutical (1)
Phase 1 (7278)
Phase 2 (10657)
Phase 3 (7673)
Pipeline (2528)
Policy (71)
Postmarket research (1229)
Preclinical (3628)
Press Release (25)
Prostate cancer (116)
Psychedelics (16)
Radiopharmaceuticals (97)
Rare diseases (307)
Real estate (1607)
Recruiting (21)
Regulatory (4881)
Reports (5)
Research institute (1537)
Resumes & cover letters (64)
Rett syndrome (9)
RNA editing (8)
RSV (18)
Schizophrenia (51)
Series A (100)
Series B (51)
Sickle cell disease (47)
Spinal muscular atrophy (52)
Sponsored (10)
Startups (1339)
Stomach cancer (1)
Supply chain (8)
Tariffs (10)
The Weekly (6)
Vaccines (358)
Venture capital (30)
Weight loss (68)
Women's health (38)
Worklife (4)
Date
Last 7 days (136)
Last 30 days (496)
Last 365 days (7647)
2026 (4127)
2025 (7800)
2024 (9178)
2023 (11089)
2022 (13656)
2021 (15633)
2020 (15281)
2019 (15292)
2018 (11191)
2017 (10346)
2016 (10518)
2015 (12006)
2014 (9091)
2013 (8806)
2012 (8880)
2011 (8888)
2010 (8147)
Location
Africa (317)
Alabama (21)
Alaska (3)
Arizona (93)
Arkansas (7)
Asia (12471)
Australia (3001)
California (3520)
Canada (961)
China (383)
Colorado (138)
Connecticut (134)
Delaware (97)
Europe (43487)
Florida (438)
Georgia (125)
Idaho (13)
Illinois (272)
India (18)
Indiana (155)
Iowa (9)
Japan (216)
Kansas (24)
Kentucky (9)
Louisiana (20)
Maine (17)
Maryland (385)
Massachusetts (2486)
Michigan (75)
Minnesota (161)
Mississippi (4)
Missouri (57)
Montana (6)
Nebraska (6)
Nevada (36)
New Hampshire (13)
New Jersey (970)
New Mexico (9)
New York (1055)
North Carolina (536)
North Dakota (4)
Northern California (1905)
Ohio (132)
Oklahoma (10)
Oregon (13)
Pennsylvania (655)
Puerto Rico (5)
Rhode Island (20)
South America (356)
South Carolina (18)
Southern California (1304)
Tennessee (73)
Texas (597)
United States (12487)
Utah (118)
Virginia (94)
Washington D.C. (19)
Washington State (297)
West Virginia (2)
Wisconsin (43)
215,283 Results for "university college london ucl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas
June 16, 2026
·
5 min read
Press Releases
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
June 28, 2026
·
5 min read
Press Releases
Decoy Therapeutics’ CEO to Participate in hVIVO Capital Markets Day in London
June 8, 2026
·
3 min read
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
·
6 min read
Press Releases
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
July 8, 2026
·
6 min read
Press Releases
Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London
July 6, 2026
·
13 min read
Pharm Country
RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
RespireRx Pharmaceuticals Inc. is pleased to announce the entering into a material transfer agreement with University College London as part of a collaborative research effort involving Dr. Ian Coombs and Prof. Mark Farrant, founder members of the GRIA Scientific Advisory Board of the CureGRIN Foundation and from the UCL Department of Neuroscience, Physiology, and Pharmacology.
April 5, 2023
·
14 min read
Press Releases
ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
April 17, 2025
·
4 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Pharm Country
ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
ViroCell Biologics announces a new partnership with University College London to advance Professor Persis Amrolia’s innovative chimeric antigen receptor T-cell therapy for relapsed paediatric acute lymphoblastic leukaemia.
December 12, 2023
·
4 min read
1 of 21,529
Next
